Quick Answer
Cytosorbents Corp reported Gross Profit of $26.49 million for fiscal year 2025.
Cytosorbents Corp Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $26.49M | +6.4% |
| 2024 | $24.89M | +13.4% |
| 2023 | $21.95M | +5.9% |
| 2022 | $20.73M | -35.4% |
| 2021 | $32.12M | +7.2% |
| 2020 | $29.95M | +70.3% |
| 2019 | $17.59M | +17.1% |
| 2018 | $15.01M | +55.9% |
| 2017 | $9.63M | +72.8% |
| 2016 | $5.57M | +116.1% |
| 2015 | $2.58M | +29.7% |
| 2014 | $1.99M | +289.1% |
| 2013 | $511.1K | -50.1% |
| 2012 | $1.02M | +4109.4% |
| 2011 | $24.3K | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.67M | +26.8% | -2.2% |
| June 30, 2025 | $6.81M | +4.8% | +9.8% |
| March 31, 2025 | $6.21M | -9.7% | +18.1% |
| September 30, 2024 | $5.26M | -6.3% | -19.2% |
| June 30, 2024 | $6.50M | +8.0% | -5.4% |
| March 31, 2024 | $6.87M | +26.0% | +22.6% |
| September 30, 2023 | $5.61M | +55.0% | -6.8% |
| June 30, 2023 | $6.02M | +21.7% | +10.3% |
- Cytosorbents Corp showed an increase of +6.4% in Gross Profit compared to the prior fiscal year.
- Over the 2011–2025 period, Cytosorbents Corp’s gross profit has grown by 108835.8% (from $24.3 thousand to $26.49 million).
- The most recent figure is from Cytosorbents Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: